Identifying and treating panic disorder in primary care

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 5, 2004, Pages 19-23

  Culpepper, Larry ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; PANIC; PRIMARY HEALTH CARE; PSYCHOLOGICAL ASPECT; REVIEW;

HUMANS; PANIC DISORDER; PRIMARY HEALTH CARE;

EID: 3843153042     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Eaton WW, Kessler RC, Wittchen HU, et al. Panic and panic disorder in the United States. Am J Psychiatry 1994;151:413-420
2. Dolan RT, Keller MB, Culpepper L, et al. The Primary Care Anxiety Project: initial findings. Presented at the 50th annual meeting of the American Psychiatric Association Institute on Psychiatric Services; Oct 1998; Los Angeles, Calif
3. Üstün TB, Sartorius N, eds. Mental Illness in General Health Care: An International Study. Chichester, England: Wiley Press; 1995
4. Coryell W, Endicott J, Andreasen NC, et al. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry 1988;145:292-300
5. Roy-Byrne PP, Stang P, Wittchen HU, et al. Lifetime panic-depression comorbidity in the National Comorbidity Survey: association with symptoms, impairment, course and help-seeking. Br J Psychiatry 2000;176:229-235
6. Weisberg RE, Bruce SE, Culpepper L, et al. Management of anxiety disorders in primary care: implications for psychiatrists. Presented at the 156th annual meeting of the American Psychiatric Association; May 17-22, 2003; San Francisco, Calif
7. Markowitz JS, Weissman MM, Ouellette R, et al. Quality of life in panic disorder. Arch Gen Psychiatry 1989;46:984-992
8. Klerman GL, Weissman MM, Ouellette R, et al. Panic attacks in the community: social morbidity and health care utilization. JAMA 1991;265:742-746
9. Salvador-Carulla L, Segui J, Fernandez-Cano P, et al. Costs and offset effect in panic disorders. Br J Psychiatry 1995;166(suppl 27):23-28
10. Bower P, Rowland N, Mellor CJ, et al, for the Cochrane Depression, Anxiety, and Neurosis Group. Effectiveness and cost effectiveness of counseling in primary care. Cochrane Database of Systematic Reviews. The Cochrane Library. May 28, 2003
11. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Panic Disorder. Am J Psychiatry 1998;155(suppl 5):1-34
12. Munjack DJ, Crocker B, Cabe D, et al. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks. J Clin Psychopharmacol 1989;9:22-27
13. Pohl R, Balon R, Yeragani VK, et al. Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone. Psychopathology 1989;22(suppl 1):60-67
14. Sheehan DV, Davidson J, Manschreck T, et al. Lack of efficacy of a new antidepressant (bupropion) in the treatment of panic disorder with phobias. J Clin Psychopharmacol 1983;3:28-31
15. Higuchi H, Kamata M, Yoshimoto M, et al. Panic attacks in patients with chronic schizophrenia: a complication of long-term neuroleptic treatment. Psychiatry Clin Neurosci 1999;53:91-94
16. Rickels K, Schweizer E. Panic disorder: long-term pharmacotherapy and discontinuation. J Clin Psychopharmacol 1998;18(suppl 2):12S-18S
17. Brown WA, Harrison W. Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another? J Clin Psychiatry 1995;56:30-34
18. Ballenger JC, Wheadon DE, Steiner M, et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 1998;155:36-42
19. Bandelow B. Sertraline and paroxetine in panic disorder. Presented at the 15th annual congress of the European College of Neuropsychopharmacology; Oct 5-9, 2002; Barcelona, Spain
20. Stahl S, Gegel I, Li D. Escitalopram in the treatment of panic disorder. Presented at the 23rd Congress of the Collegium Internationale NeuroPsychopharmacologicum; June 23-27, 2002; Montreal, Canada
21. Moroz G, Rosenbaum JF. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages. J Clin Psychiatry 1999;60:604-612
22. Doyle A, Pollack MH. Long-term management of panic disorder. J Clin Psychiatry 2004;65(suppl 5):24-28
23. Otto MW, Smits JAJ, Reese HE. Cognitive-behavioral therapy for the treatment of anxiety disorder. J Clin Psychiatry 2004;65(suppl 5):34-41
24. Grilo CM, Money R, Barlow DH, et al. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Compr Psychiatry 1998;39:323-332
25. Cowley DS, Ha EH, Roy-Byrne PP. Determinants of pharmacologic treatment failure in panic disorder. J Clin Psychiatry 1997;58:555-561
26. Broocks A, Bandelow B, Pekrun G, et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry 1998;155:603-609
27. Martinsen EW, Raglin JS, Hoffart A, et al. Tolerance to intensive exercise and high levels of lactate in panic disorder. J Anxiety Disord 1998;12:333-342
28. Asmundson GJ, Stein MB. Resting cardiovascular measures in patients with panic disorder and social phobia and health control subjects: relationship to habitual exercise frequency. Anxiety 1994;1:26-30
29. Katon WJ, Roy-Byrne P, Russo J, et al. Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Arch Gen Psychiatry 2002;59:1098-1104